Frank Edelmann

ORCID: 0000-0003-4401-5936
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiovascular and exercise physiology
  • Cardiac Imaging and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiac Health and Mental Health
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Hormonal Regulation and Hypertension
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Diabetes Treatment and Management
  • Cardiovascular Effects of Exercise
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Disease and Adiposity
  • Advanced MRI Techniques and Applications
  • Erythropoietin and Anemia Treatment
  • Electrolyte and hormonal disorders
  • Cardiac Arrhythmias and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Diet and metabolism studies
  • Health Systems, Economic Evaluations, Quality of Life
  • GDF15 and Related Biomarkers
  • Cardiomyopathy and Myosin Studies
  • Nutrition and Health in Aging

German Centre for Cardiovascular Research
2016-2025

Charité - Universitätsmedizin Berlin
2016-2025

Humboldt-Universität zu Berlin
2020-2025

Freie Universität Berlin
2020-2025

Deutsches Herzzentrum der Charité
2019-2025

Universitätsmedizin Göttingen
2011-2025

Sequoia (United States)
2024

SEQUOIA (Italy)
2024

Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2017-2024

Deutsches Herzzentrum München
2023-2024

Abstract Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains challenge. We recommend new stepwise diagnostic process, the ‘HFA–PEFF algorithm’. Step 1 (P=Pre-test assessment) is typically performed in ambulatory setting and includes assessment for HF symptoms signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), laboratory tests, electrocardiogram, echocardiography. In absence overt...

10.1093/eurheartj/ehz641 article EN European Heart Journal 2019-08-27
Theresa A. McDonagh Marco Metra Marianna Adamo Roy S. Gardner Andreas Baumbach and 95 more Michael Böhm Haran Burri Javed Butler Jelena Čelutkienė Ovidiu Chioncel John G.F. Cleland María G. Crespo‐Leiro Dimitrios Farmakis Martine Gilard Stéphane Heymans Arno W. Hoes Tiny Jaarsma Ewa A. Jankowska Mitja Lainščak Carolyn S.P. Lam Alexander R. Lyon John J.V. McMurray Alexandre Mebazaa Richard Mindham Claudio Muneretto Massimo Piepoli Susanna Price Giuseppe Rosano Frank Ruschitzka Anne Kathrine Skibelund Rudolf A. de Boer P. Christian Schulze Elena Arbelo Jozef Bartúnek Johann Bauersachs Michael A. Borger Sergio Buccheri Elisabetta Cerbai Erwan Donal Frank Edelmann Gloria Färber Bettina Heidecker Borja Ibáñez Stefan James Lars Køber Konstantinos C. Koskinas Josep Masip John W. McEvoy Robert J. Mentz Borislava Mihaylova Jacob Eifer Møller Wilfried Müllens Lis Neubeck Jens Cosedis Nielsen Agnès Pasquet Piotr Ponikowski Eva Prescott Amina Rakisheva Bianca Rocca Xavier Rosselló Leyla Elif Sade Hannah Schaubroeck Elena Tessitore Mariya Tokmakova Peter van der Meer Isabelle C. Van Gelder Mattias Van Heetvelde Christiaan Vrints Matthias Wilhelm Adam Witkowski Katja Zeppenfeld Naltin Shuka Mohammed Chettibi Hamlet Hayrapetyan Noémi Pávó Aysel İslamlı Anne‐Catherine Pouleur Zumreta Kušljugić Mariya Tokmakova Davor Miličić Theodoros Christodoulides Filip Málek Lars Køber M. Koriem Pentti Põder Johan Lassus François Roubille Vaja Agladze Stefan Frantz Alexia Stavrati Annamária Kosztin Inga Jóna Ingimarsdóttir Patricia Campbell Tal Hasin Fabrizio Oliva Nazipa Aidargaliyeva Gani Bajraktari Erkin М Мirrakhimov Ginta Kamzola Ali M El Neihoum

Poland), and Katja Zeppenfeld (

10.1093/eurheartj/ehad195 article EN European Heart Journal 2023-08-25

Diastolic heart failure (ie, with preserved ejection fraction) is a common condition without established therapy, and aldosterone stimulation may contribute to its progression.To assess the efficacy safety of long-term receptor blockade in fraction. The primary objective was determine whether spironolactone superior placebo improving diastolic function maximal exercise capacity patients fraction.The Aldo-DHF trial, multicenter, prospective, randomized, double-blind, placebo-controlled trial...

10.1001/jama.2013.905 article EN JAMA 2013-02-27

<h3>Importance</h3> Depression is frequent in patients with heart failure and associated adverse clinical outcomes. Long-term efficacy safety of selective serotonin reuptake inhibitors these are unknown. <h3>Objective</h3> To determine whether 24 months treatment escitalopram improves mortality, morbidity, mood chronic systolic depression. <h3>Design, Setting, Participants</h3> The Effects Selective Serotonin Re-Uptake Inhibition on Morbidity, Mortality, Mood Depressed Heart Failure Patients...

10.1001/jama.2016.7635 article EN JAMA 2016-06-28

Cardiovascular Magnetic Resonance myocardial feature tracking (CMR-FT) is a quantitative technique tissue voxel motion on standard steady-state free precession (SSFP) cine images to assess ventricular deformation. The importance of left atrial (LA) deformation assessment increasingly recognized and can be assessed with echocardiographic speckle tracking. However quantification has never previously been demonstrated CMR. We sought determine the feasibility reproducibility CMR-FT for...

10.1186/s12968-014-0060-6 article EN cc-by Journal of Cardiovascular Magnetic Resonance 2014-08-11

This study sought to confirm a subgroup analysis of the prior FIX-HF-5 (Evaluate Safety and Efficacy OPTIMIZER System in Subjects With Moderate-to-Severe Heart Failure) showing that cardiac contractility modulation (CCM) improved exercise tolerance (ET) quality life patients with ejection fractions between 25% 45%.CCM therapy for New York Association (NYHA) functional class III IV heart failure (HF) consists nonexcitatory electrical signals delivered during absolute refractory period.A total...

10.1016/j.jchf.2018.04.010 article EN cc-by-nc-nd JACC Heart Failure 2018-05-10

<h3>Importance</h3> Endurance exercise is effective in improving peak oxygen consumption (peak V̇o<sub>2</sub>) patients with heart failure preserved ejection fraction (HFpEF). However, it remains unknown whether differing modes of have different effects. <h3>Objective</h3> To determine high-intensity interval training, moderate continuous and guideline-based advice on physical activity effects change V̇o<sub>2</sub>in HFpEF. <h3>Design, Setting, Participants</h3> Randomized clinical trial...

10.1001/jama.2020.26812 article EN JAMA 2021-02-09

Background and Purpose— Diagnosis of paroxysmal atrial fibrillation is difficult but highly relevant in patients presenting with cerebral ischemia yet free from on admission. Early initiation prolongation continuous Holter monitoring may improve diagnostic yield compared the standard care including a 24-hour recording. Methods— In observational Find-AF trial (ISRCTN 46104198), consecutive symptoms were included. Patients at presentation received 7-day monitoring. Results— Two hundred...

10.1161/strokeaha.110.591958 article EN Stroke 2010-10-22

The aim of the present multicentre study was to analyse a large cohort healthy subjects and patients with common condition such as heart failure (HF) purpose determining normal range usefulness right ventricular (RV) systolic strain detect subtle RV abnormalities using 2D speckle-tracking echocardiography.We analysed 238 642 characterized by asymptomatic (n = 216) HF preserved (HFpEF) reduced (HFrEF) ejection fraction 218 n 208, respectively) prospectively included in 10 centres. analysing...

10.1093/ehjci/jew011 article EN European Heart Journal - Cardiovascular Imaging 2016-02-11

Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF-15) elevated in systolic heart (HFrEF) and predictive of adverse outcome. We investigated the relevance GDF-15 plasma levels HFnEF.A subgroup patients from ongoing DIAST-CHF observational trial, a history chronic (CHF) or positive Framingham criteria at presentation, was selected. Patients were classified as having...

10.1093/eurjhf/hfq151 article EN cc-by-nc European Journal of Heart Failure 2010-09-14

Hyperglycaemia and insulin resistance have been linked to diastolic dysfunction experimentally. We investigated the association between glucose metabolism function along whole spectrum of states. In observational Diagnostic Trial on Prevalence Clinical Course Diastolic Dysfunction Heart Failure (DIAST-CHF) study, patients with risk factors for heart failure were included. analysed data including comprehensive echocardiography from a subgroup classified by OGTT history as normal (n = 343),...

10.1007/s00125-010-1718-8 article EN cc-by-nc Diabetologia 2010-04-12

General self-efficacy has been found to be an influential variable related the adaptation stress and chronic illness, with Self-Efficacy (GSE) Scale by Jerusalem Schwarzer being a reliable valid instrument assess this disposition. The aim of study was construct test short form scale allow for more economical assessment construct.The item characteristics original were assessed using intercultural non-clinical sample (n=19,719). Six items highest coefficient variation good discrimination along...

10.3205/psm000091 article DE PubMed 2013-01-01

Abstract Aims To investigate the effects of spironolactone on fibrosis and cardiac function in people at increased risk developing heart failure. Methods results Randomized, open-label, blinded-endpoint trial comparing (50 mg/day) or control for up to 9 months with, high of, coronary disease raised plasma B-type natriuretic peptides. The primary endpoint was interaction between baseline serum galectin-3 changes procollagen type-III N-terminal pro-peptide (PIIINP) participants assigned...

10.1093/eurheartj/ehaa758 article EN cc-by-nc European Heart Journal 2020-09-05
Philipp S. Wild Janine F. Felix Arne Schillert Alexander Teumer Ming‐Huei Chen and 95 more Maarten J.G. Leening Uwe Völker Vera Großmann Jennifer A. Brody Marguerite R. Irvin Sanjiv J. Shah Setia Pramana Wolfgang Lieb Reinhold Schmidt Alice Stanton Dörthe Malzahn Albert V. Smith Johan Sundström Cosetta Minelli Daniela Ruggiero Leo‐Pekka Lyytikäinen Daniel Tiller J. G. Smith Claire Monnereau Marco R. Di Tullio Solomon K. Musani Alanna C. Morrison Tune H. Pers Michael P. Morley Marcus E. Kleber Jayashri Aragam Emelia J. Benjamin Joshua C. Bis Egbert Bisping Ulrich Broeckel Susan Cheng Jaap W. Deckers Fabiola Del Greco M Frank Edelmann Myriam Fornage Lude Franke Nele Friedrich Tamara B. Harris Edith Hofer Albert Hofman Jie Huang Alun D. Hughes Mika Kähönen KNHI investigators Jochen Kruppa Karl J. Lackner Lars Lannfelt Rafael Laskowski Lenore J. Launer Margrét Leósdóttir Honghuang Lin Cecilia M. Lindgren Christina Loley Calum A. MacRae Deborah Mascalzoni Jamil Mayet Daniel Medenwald Andrew P. Morris Christian Müller Martina Müller‐Nurasyid Stefania Nappo Peter M. Nilsson Sebastian Nuding Teresa Nutile Annette Peters Arne Pfeufer Diana Pietzner Peter P. Pramstaller Olli T. Raitakari Kenneth Rice Fernando Rivadeneira Jerome I. Rotter Saku Ruohonen Ralph L. Sacco Tandaw E. Samdarshi Helena Schmidt Andrew Sharp Denis C. Shields Rossella Sorice Nona Sotoodehnia Bruno H. Stricker Praveen Surendran Simon Thom Anna Maria Töglhofer André G. Uitterlinden Rolf Wachter Henry Völzke Andreas Ziegler Thomas Münzel Winfried März Thomas P. Cappola Joel N. Hirschhorn Gary F. Mitchell Nicholas L. Smith Ervin R. Fox

Understanding the genetic architecture of cardiac structure and function may help to prevent treat heart disease. This investigation sought identify common variations associated with inter-individual variability in function.

10.1172/jci84840 article EN Journal of Clinical Investigation 2017-04-09
Coming Soon ...